Stocktoria
Heartflow, Inc. HTFL
Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2025-08-08
Heartflow, Inc. financials (annual)
Bars are annual figures from 2024 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue | $176.0M | $125.8M |
| Gross profit | $135.2M | $94.4M |
| R&D expense | $64.9M | $43.5M |
| SG&A expense | $134.3M | $112.2M |
| Operating income | -$64.1M | -$61.2M |
| Income tax | -$76,000 | $53,000 |
| Net income | -$116.8M | -$96.4M |
| EPS (diluted) | $-3.17 | $-17.98 |
| Operating cash flow | -$54.0M | -$69.0M |
| Free cash flow | -$59.0M | -$73.4M |
| Cash & equivalents | $44.8M | $51.4M |
| Total assets | $359.5M | $118.7M |
| Total liabilities | $58.8M | $209.6M |
| Shareholders' equity | $300.6M | -$859.5M |
Growth · year-over-year · Revenue CAGR 39.9%
| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue growth | +39.9% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.